top of page

Biopsy Portfolio- Coming Soon

Management of severe diseases starts with excellent biopsy samples.

 

RESTARI's emerging biopsy device portfolio uses patented technology to capture biopsy samples of superior quality and size so skilled physicians have more of the best material to work with. 

​

Coming Soon - MorCor

MorCor Sample GIF.gif

RESTARI's MorCor full core biopsy device takes excellent biopsy specimens without the fragmentation of side notch devices.

MorCor pathology vert.png

'Linear samples exhibited no crush artifact or cellular distortion". (RESTARI Data on File).

MorCor pathology Hor.png

"Overall the specimens were 90% better than similarly acquired tissues." A prominent pathologist's summary. (RESTARI Data on File).

Picture12.png

MorCor theoretical sample volumes surpass side notch volume. (RESTARI Data on File).

More Sample Weight.png

MorCor's samples weighted notably more than prominent competitor's samples. (RESTARI Data on File).

Pathology Department Chair
​
"Thinking of MorCor right now with these horrible stereotactic breast core biopsies that I just received.
Tons of contamination with blood, the tissue was all fragmented and going every which way.
 
It literally looks like they ran it over with a truck before giving it to me. This makes it much harder to look at under the microscope.
​
I'm waiting for you to save us!"

Status

Coming soon - RESTARI's biopsy device portfolio is in late-stage development and is not yet cleared by any regulatory agency.

bottom of page